Cargando…

Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab

Detalles Bibliográficos
Autores principales: Kuba, Kiyomi, Inoue, Hitoshi, Matsumura, Satoko, Enoki, Yuichiro, Kogashiwa, Yasunao, Ebihara, Yasuhiro, Nakahira, Mitsuhiko, Yamazaki, Tomoko, Yasuda, Masanari, Kaira, Kyoichi, Kagamu, Hiroshi, Sugasawa, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212916/
https://www.ncbi.nlm.nih.gov/pubmed/37231164
http://dx.doi.org/10.1038/s41598-023-35683-7
_version_ 1785047516639657984
author Kuba, Kiyomi
Inoue, Hitoshi
Matsumura, Satoko
Enoki, Yuichiro
Kogashiwa, Yasunao
Ebihara, Yasuhiro
Nakahira, Mitsuhiko
Yamazaki, Tomoko
Yasuda, Masanari
Kaira, Kyoichi
Kagamu, Hiroshi
Sugasawa, Masashi
author_facet Kuba, Kiyomi
Inoue, Hitoshi
Matsumura, Satoko
Enoki, Yuichiro
Kogashiwa, Yasunao
Ebihara, Yasuhiro
Nakahira, Mitsuhiko
Yamazaki, Tomoko
Yasuda, Masanari
Kaira, Kyoichi
Kagamu, Hiroshi
Sugasawa, Masashi
author_sort Kuba, Kiyomi
collection PubMed
description
format Online
Article
Text
id pubmed-10212916
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102129162023-05-27 Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab Kuba, Kiyomi Inoue, Hitoshi Matsumura, Satoko Enoki, Yuichiro Kogashiwa, Yasunao Ebihara, Yasuhiro Nakahira, Mitsuhiko Yamazaki, Tomoko Yasuda, Masanari Kaira, Kyoichi Kagamu, Hiroshi Sugasawa, Masashi Sci Rep Author Correction Nature Publishing Group UK 2023-05-25 /pmc/articles/PMC10212916/ /pubmed/37231164 http://dx.doi.org/10.1038/s41598-023-35683-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Kuba, Kiyomi
Inoue, Hitoshi
Matsumura, Satoko
Enoki, Yuichiro
Kogashiwa, Yasunao
Ebihara, Yasuhiro
Nakahira, Mitsuhiko
Yamazaki, Tomoko
Yasuda, Masanari
Kaira, Kyoichi
Kagamu, Hiroshi
Sugasawa, Masashi
Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
title Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
title_full Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
title_fullStr Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
title_full_unstemmed Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
title_short Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
title_sort author correction: a retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212916/
https://www.ncbi.nlm.nih.gov/pubmed/37231164
http://dx.doi.org/10.1038/s41598-023-35683-7
work_keys_str_mv AT kubakiyomi authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT inouehitoshi authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT matsumurasatoko authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT enokiyuichiro authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT kogashiwayasunao authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT ebiharayasuhiro authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT nakahiramitsuhiko authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT yamazakitomoko authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT yasudamasanari authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT kairakyoichi authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT kagamuhiroshi authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab
AT sugasawamasashi authorcorrectionaretrospectiveanalysisoftumorinfiltratinglymphocytesinheadandnecksquamouscellcarcinomapatientstreatedwithnivolumab